Phase Holographic Imaging AB:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Phase Holographic Imaging AB - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0123
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phase Holographic Imaging AB (PHI) is a medical device company that develops time-lapse cytometry instrumentation and software. The company’s products include HoloMonitor M4 and demo software. Its HoloMonitor time-lapse cytometers provides cellular behavior to be continuously quantified and monitored. PHI’s products are used in various applications such as cell cycle, toxicology, cell motility, cell viability and time-lapse cytometry. The company has partnership with healthcare companies located in Australia, China, Japan, Korea, Malaysia, Poland, Czech Republic, France, Sweden, Germany, Switzerland, Hungary, Israel, Italy, Taiwan, the US, and the UK. It markets its products through a network of international distributors. PHI is headquartered in Lund, Sweden.

Phase Holographic Imaging AB – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Phase Holographic Imaging AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Phase Holographic Imaging AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Phase Holographic Imaging AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Phase Holographic Imaging AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Phase Holographic Imaging AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Phase Holographic Imaging AB, Medical Equipment, Deal Details 10
Partnerships 10
Phase Holographic Imaging and BioSpherix Enter into Co-Marketing Agreement 10
Phase Holographic Imaging Enters into Agreement with University of California, San Francisco 11
Phase Holographic Imaging Enters into Co-Development Agreement with Northeastern University 12
Phase Holographic Imaging AB – Key Competitors 13
Phase Holographic Imaging AB – Key Employees 14
Phase Holographic Imaging AB – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Financial Announcements 16
May 04, 2018: PHI increase sales in fourth quarter, as well 16
Mar 12, 2018: Phase Holographic Imaging PHI Reports Q3 Fiscal 2018 Results 17
Jun 19, 2017: Phase Holographic Imaging: Year-end Report (2016-05-01 – 2017-04-30) 19
Product News 21
Feb 20, 2018: Novel HoloMonitor method identifies tumor creating cancer cells 21
Other Significant Developments 22
May 02, 2018: PHI and world-leading research institute evaluate quantitative imaging of living tumor cells 22
Nov 20, 2017: PHI and Germany’s federal institute for materials research pursue joint patent application 23
Mar 20, 2017: Phase Holographic Imaging and Malmo University receives 2.3 million kronor to detect blood-borne cancer cells 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Phase Holographic Imaging AB, Medical Equipment, Key Facts 2
Phase Holographic Imaging AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Phase Holographic Imaging AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Phase Holographic Imaging AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Phase Holographic Imaging AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Phase Holographic Imaging AB, Deals By Market, 2012 to YTD 2018 8
Phase Holographic Imaging AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Phase Holographic Imaging and BioSpherix Enter into Co-Marketing Agreement 10
Phase Holographic Imaging Enters into Agreement with University of California, San Francisco 11
Phase Holographic Imaging Enters into Co-Development Agreement with Northeastern University 12
Phase Holographic Imaging AB, Key Competitors 13
Phase Holographic Imaging AB, Key Employees 14

List of Figures
Phase Holographic Imaging AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Phase Holographic Imaging AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Phase Holographic Imaging AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Phase Holographic Imaging AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Phase Holographic Imaging AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Phase Holographic Imaging AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Phase Holographic Imaging AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Phase Holographic Imaging AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Phase Holographic Imaging AB:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sisaf Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Coca-Cola HBC-Srbija d.o.o.:企業の戦略・SWOT・財務分析
    Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Antitope Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T cell epitope database is used for screening amino acid sequences from antibo …
  • Transocean Ltd.:戦略・SWOT・企業財務分析
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Alliant Energy Corporation (LNT)-エネルギー分野:企業M&A・提携分析
    Summary Alliant Energy Corporation (Alliant Energy) is an energy utility holding company. Through subsidiaries, it carries out generation and distribution of electricity and distribution and transportation of natural gas. The company operates through Interstate Power and Light Company (IPL) and Wisc …
  • GAIL (India) Ltd (GAIL)-石油・ガス分野:企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Dolphin Hotels plc:企業の戦略・SWOT・財務分析
    Dolphin Hotels plc - Strategy, SWOT and Corporate Finance Report Summary Dolphin Hotels plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Stada Arzneimittel AG (SAZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of product …
  • Beach Energy Limited:企業の戦略・SWOT・財務分析
    Beach Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Beach Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Edwards Lifesciences Corporation:企業の戦略・SWOT・財務情報
    Edwards Lifesciences Corporation - Strategy, SWOT and Corporate Finance Report Summary Edwards Lifesciences Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Evofem Inc-製薬・医療分野:企業M&A・提携分析
    Summary Evofem Inc (Evofem) is a healthcare solution provider that discovers, develops and commercializes prescription and consumer products. The company’s product pipeline includes amphora and nestorone. Evofem improves reproductive health and wellness options for women. It develops products for co …
  • Knight Therapeutics Inc (GUD):企業の財務・戦略的SWOT分析
    Summary Knight Therapeutics Inc (Knight Therapeutics) focuses on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. The company offers tablets to treat metabolic, renal diseases and cancer; and injections against chronic pain and hormone …
  • Daxor Corp (DXR):企業の財務・戦略的SWOT分析
    Daxor Corp (DXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Catalyst Pharmaceuticals Inc (CPRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LE …
  • YTL Power International Bhd (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Kuwait Oil Co:企業の戦略的SWOT分析
    Kuwait Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • McCarthy Building Companies Inc:企業の戦略・SWOT・財務情報
    McCarthy Building Companies Inc - Strategy, SWOT and Corporate Finance Report Summary McCarthy Building Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ZIOPHARM Oncology Inc (ZIOP)-製薬・医療分野:企業M&A・提携分析
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease …
  • Transocean Ltd (RIG):石油・ガス:M&Aディール及び事業提携情報
    Summary Transocean Ltd (Transocean) is a provider of offshore contract drilling services to the oil and gas industry. The company specializes in the technically demanding regions of the global offshore drilling business with a particular focus on deepwater and harsh environment drilling services. Tr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆